Literature DB >> 31194700

Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer.

Ruth E Musgrove1, Michael Helwig1, Eun-Jin Bae1,2, Helia Aboutalebi1, Seung-Jae Lee2, Ayse Ulusoy1, Donato A Di Monte1.   

Abstract

Specific neuronal populations display high vulnerability to pathological processes in Parkinson's disease (PD). The dorsal motor nucleus of the vagus nerve (DMnX) is a primary site of pathological α-synuclein deposition and may play a key role in the spreading of α-synuclein lesions within and outside the CNS. Using in vivo models, we show that cholinergic neurons forming this nucleus are particularly susceptible to oxidative challenges and accumulation of reactive oxidative species (ROS). Targeted α-synuclein overexpression within these neurons triggered an oxidative stress that became significantly more pronounced after exposure to the ROS-generating agent paraquat. A more severe oxidative stress resulted in enhanced production of oxidatively modified forms of α-synuclein, increased α-synuclein aggregation into oligomeric species and marked degeneration of DMnX neurons. Enhanced oxidative stress also affected neuron-to-neuron protein transfer, causing an increased spreading of α-synuclein from the DMnX toward more rostral brain regions. In vitro experiments confirmed a greater propensity of α-synuclein to pass from cell to cell under pro-oxidant conditions, and identified nitrated α-synuclein forms as highly transferable protein species. These findings substantiate the relevance of oxidative injury in PD pathogenetic processes, establish a relationship between oxidative stress and vulnerability to α-synuclein pathology and define a new mechanism, enhanced cell-to-cell α-synuclein transmission, by which oxidative stress could promote PD development and progression.

Entities:  

Keywords:  Neurodegeneration; Neuroscience; Parkinson's disease; Protein misfolding

Mesh:

Substances:

Year:  2019        PMID: 31194700      PMCID: PMC6715407          DOI: 10.1172/JCI127330

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  70 in total

1.  NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Du-Chu Wu; Peter Teismann; Kim Tieu; Miquel Vila; Vernice Jackson-Lewis; Harry Ischiropoulos; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

2.  Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers.

Authors:  Ghiam Yamin; Vladimir N Uversky; Anthony L Fink
Journal:  FEBS Lett       Date:  2003-05-08       Impact factor: 4.124

Review 3.  Oxidative stress and nitration in neurodegeneration: cause, effect, or association?

Authors:  Harry Ischiropoulos; Joseph S Beckman
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

4.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

Review 5.  The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?

Authors:  Donato A Di Monte
Journal:  Lancet Neurol       Date:  2003-09       Impact factor: 44.182

6.  Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.

Authors:  M Hashimoto; L J Hsu; Y Xia; A Takeda; A Sisk; M Sundsmo; E Masliah
Journal:  Neuroreport       Date:  1999-03-17       Impact factor: 1.837

7.  Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies.

Authors:  J E Duda; B I Giasson; Q Chen; T L Gur; H I Hurtig; M B Stern; S M Gollomp; H Ischiropoulos; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

8.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

Authors:  B I Giasson; J E Duda; I V Murray; Q Chen; J M Souza; H I Hurtig; H Ischiropoulos; J Q Trojanowski; V M Lee
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

9.  Induction of alpha-synuclein aggregation by intracellular nitrative insult.

Authors:  E Paxinou; Q Chen; M Weisse; B I Giasson; E H Norris; S M Rueter; J Q Trojanowski; V M Lee; H Ischiropoulos
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

10.  Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.

Authors:  John E Duda; Benoit I Giasson; Meghann E Mabon; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2002-08       Impact factor: 10.422

View more
  38 in total

Review 1.  Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson's Disease: a Systematic Review.

Authors:  Michele Goulart Dos Santos; Lucia Emanueli Schimith; Corinne André-Miral; Ana Luiza Muccillo-Baisch; Bruno Dutra Arbo; Mariana Appel Hort
Journal:  Neurotox Res       Date:  2022-01-11       Impact factor: 3.911

2.  Mitochondrial dysfunction triggers the pathogenesis of Parkinson's disease in neuronal C/EBPβ transgenic mice.

Authors:  Eun Hee Ahn; Kecheng Lei; Seong Su Kang; Zhi-Hao Wang; Xia Liu; Wei Hong; Yu Tian Wang; Laura E Edgington-Mitchell; Lingjing Jin; Keqiang Ye
Journal:  Mol Psychiatry       Date:  2021-09-06       Impact factor: 15.992

Review 3.  COVID-19 and Parkinson's Disease: Possible Links in Pathology and Therapeutics.

Authors:  Shubhangini Tiwari; Neelam Yadav; Sarika Singh
Journal:  Neurotox Res       Date:  2022-07-13       Impact factor: 3.978

Review 4.  Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson's Disease: A Narrative Review.

Authors:  Jeremy M Morowitz; Kaylyn B Pogson; Daniel A Roque; Frank C Church
Journal:  Brain Sci       Date:  2022-04-22

5.  Oxidative stress and α-synuclein conspire in vulnerable neurons to promote Parkinson's disease progression.

Authors:  Kelvin C Luk
Journal:  J Clin Invest       Date:  2019-08-05       Impact factor: 14.808

6.  Inhibition of α-Synuclein Accumulation Improves Neuronal Apoptosis and Delayed Postoperative Cognitive Recovery in Aged Mice.

Authors:  Yue Li; Yi Yuan; Yitong Li; Dengyang Han; Taotao Liu; Ning Yang; Xinning Mi; Jingshu Hong; Kaixi Liu; Yanan Song; Jindan He; Yang Zhou; Yongzheng Han; Chengmei Shi; Shun Yu; Peng Zou; Xiangyang Guo; Zhengqian Li
Journal:  Oxid Med Cell Longev       Date:  2021-05-28       Impact factor: 6.543

Review 7.  Roles of Phase Separation for Cellular Redox Maintenance.

Authors:  Yuichi Saito; Wataru Kimura
Journal:  Front Genet       Date:  2021-07-09       Impact factor: 4.599

8.  α-synuclein aggregates induce c-Abl activation and dopaminergic neuronal loss by a feed-forward redox stress mechanism.

Authors:  Soumitra Ghosh; Seok Joon Won; Jiejie Wang; Rebecca Fong; Nicholas J M Butler; Arianna Moss; Candance Wong; June Pan; Jennifer Sanchez; Annie Huynh; Long Wu; Fredric P Manfredsson; Raymond A Swanson
Journal:  Prog Neurobiol       Date:  2021-05-02       Impact factor: 10.885

Review 9.  Brain organoids: A promising model to assess oxidative stress-induced central nervous system damage.

Authors:  Foluwasomi A Oyefeso; Alysson R Muotri; Christopher G Wilson; Michael J Pecaut
Journal:  Dev Neurobiol       Date:  2021-05-18       Impact factor: 3.102

Review 10.  Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling.

Authors:  Pooja Jadiya; Joanne F Garbincius; John W Elrod
Journal:  Acta Neuropathol Commun       Date:  2021-07-07       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.